Clinical Study to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients

Trial Profile

Clinical Study to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Oct 2015

At a glance

  • Drugs Ciprofloxacin/fluocinolone acetonide (Primary) ; Ciprofloxacin; Fluocinolone acetonide
  • Indications Bacterial infections; Otitis media
  • Focus Therapeutic Use
  • Sponsors SALVAT
  • Most Recent Events

    • 02 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 18 Jul 2013 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 28 May 2013 Status changed from recruiting to active, no longer recruiting, as reported by a SALVAT media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top